Description: We are GG 1978 SICAF SIF SA, a closed-ended investment fund focusing on pharmaceuticals and biotechnologies.
The Fund aims to combine an entrepreneurial approach with financial discipline. We focus on the development of strategic businesses, striving to improve their competitive position and profitability.
Our goal is to generate long-term capital gains in both private and public companies. We specialize in the human medicine, biotechnology, medical technology and diagnostics sectors.
We build our strategic positions by investing in private companies with development potential. We then expand during follow-on financing rounds, as well as through IPOs.